Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2013115772) METHOD AND APPARATUS FOR DETECTING CANCER IN MAMMALS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/115772 International Application No.: PCT/US2012/023135
Publication Date: 08.08.2013 International Filing Date: 30.01.2012
IPC:
C12Q 1/68 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
Applicants:
RINGOLD, Randy [US/US]; US
Inventors:
RINGOLD, Randy; US
Agent:
LAGOBI, Karim; 420 North Myers St. Burbank, CA 91506, US
Priority Data:
Title (EN) METHOD AND APPARATUS FOR DETECTING CANCER IN MAMMALS
(FR) PROCÉDÉ ET APPAREIL DE DÉTECTION D'UN CANCER CHEZ DES MAMMIFÈRES
Abstract:
(EN) A method and apparatus for detecting cancer using the measurement of acute-phase proteins (APPs) and the measurement of thymidine kinase activiy level in body fluids. A set of biochemical tests is implemented to measure the concentration of one or more APPs along with the measurement of the activity level of thymidine kinase, and compute an index that allows a practitioner to rule in, or rule out, the presence of cancer during a diagnostic. An index is calculated based on the measured data and compared with a pre-established reference that allows a practitioner to determine a high probabilty that a patient is a carrier of cancer.
(FR) L'invention concerne un procédé et un appareil qui permettent de détecter un cancer à l'aide de la mesure de protéines de phase aiguë (APPs) et de la mesure du niveau d'activité thymidine kinase dans les liquides corporels. Un indice est calculé sur la base des données mesurées et comparé à une référence pré-établie qui permet à un praticien de déterminer une probabilité élevée qu'un patient est porteur d'un cancer.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)